130 related articles for article (PubMed ID: 1397059)
1. Serotonin inhibits adenylate cyclase in human platelet membranes.
Newman ME
Eur J Pharmacol; 1992 Aug; 226(4):281-5. PubMed ID: 1397059
[TBL] [Abstract][Full Text] [Related]
2. Activity of serotonin (5-HT) receptor agonists, partial agonists and antagonists at cloned human 5-HT1A receptors that are negatively coupled to adenylate cyclase in permanently transfected HeLa cells.
Pauwels PJ; Van Gompel P; Leysen JE
Biochem Pharmacol; 1993 Jan; 45(2):375-83. PubMed ID: 8382063
[TBL] [Abstract][Full Text] [Related]
3. 5-HT1B receptors are negatively coupled with adenylate cyclase in rat substantia nigra.
Bouhelal R; Smounya L; Bockaert J
Eur J Pharmacol; 1988 Jul; 151(2):189-96. PubMed ID: 2971554
[TBL] [Abstract][Full Text] [Related]
4. Serotonin inhibition of adenylate cyclase in human platelet membranes; relation to 5-HT-1A receptor-mediated activity.
Newman ME
Biochem Pharmacol; 1994 Nov; 48(9):1677-82. PubMed ID: 7980635
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of forskolin-stimulated adenylate cyclase activity by 5-HT receptor agonists.
Devivo M; Maayani S
Eur J Pharmacol; 1985 Dec; 119(3):231-4. PubMed ID: 2936612
[TBL] [Abstract][Full Text] [Related]
6. Stimulation and inhibition of adenylyl cyclase by distinct 5-hydroxytryptamine receptors.
De Vivo M; Maayani S
Biochem Pharmacol; 1990 Oct; 40(7):1551-8. PubMed ID: 2222510
[TBL] [Abstract][Full Text] [Related]
7. Centrally acting hypotensive agents with affinity for 5-HT1A binding sites inhibit forskolin-stimulated adenylate cyclase activity in calf hippocampus.
Schoeffter P; Hoyer D
Br J Pharmacol; 1988 Nov; 95(3):975-85. PubMed ID: 3207999
[TBL] [Abstract][Full Text] [Related]
8. 5-Hydroxytryptamine 5-HT1B and 5-HT1D receptors mediating inhibition of adenylate cyclase activity. Pharmacological comparison with special reference to the effects of yohimbine, rauwolscine and some beta-adrenoceptor antagonists.
Schoeffter P; Hoyer D
Naunyn Schmiedebergs Arch Pharmacol; 1989 Sep; 340(3):285-92. PubMed ID: 2572975
[TBL] [Abstract][Full Text] [Related]
9. Inhibition by 5-HT of forskolin-induced cAMP formation in the renal opossum epithelial cell line OK: mediation by a 5-HT1B like receptor and antagonism by methiothepin.
Pauwels PJ; Palmier C
Neuropharmacology; 1994 Jan; 33(1):67-75. PubMed ID: 7910388
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the 5-hydroxytryptamine1a receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in guinea pig and rat hippocampal membranes.
De Vivo M; Maayani S
J Pharmacol Exp Ther; 1986 Jul; 238(1):248-53. PubMed ID: 2941565
[TBL] [Abstract][Full Text] [Related]
11. Effects of postmortem delay on serotonin and (+)8-OH-DPAT-mediated inhibition of adenylyl cyclase activity in rat and human brain tissues.
Palego L; Giromella A; Marazziti D; Borsini F; Naccarato AG; Giannaccini G; Lucacchini A; Cassano GB; Mazzoni MR
Brain Res; 1999 Jan; 816(1):165-74. PubMed ID: 9878719
[TBL] [Abstract][Full Text] [Related]
12. The 5-hydroxytryptamine 5-HT1D receptor subtype is negatively coupled to adenylate cyclase in calf substantia nigra.
Schoeffter P; Waeber C; Palacios JM; Hoyer D
Naunyn Schmiedebergs Arch Pharmacol; 1988 Jun; 337(6):602-8. PubMed ID: 3216894
[TBL] [Abstract][Full Text] [Related]
13. Cloning of another human serotonin receptor (5-HT1F): a fifth 5-HT1 receptor subtype coupled to the inhibition of adenylate cyclase.
Adham N; Kao HT; Schecter LE; Bard J; Olsen M; Urquhart D; Durkin M; Hartig PR; Weinshank RL; Branchek TA
Proc Natl Acad Sci U S A; 1993 Jan; 90(2):408-12. PubMed ID: 8380639
[TBL] [Abstract][Full Text] [Related]
14. Lack of apparent receptor reserve at postsynaptic 5-hydroxytryptamine1A receptors negatively coupled to adenylyl cyclase activity in rat hippocampal membranes.
Yocca FD; Iben L; Meller E
Mol Pharmacol; 1992 Jun; 41(6):1066-72. PubMed ID: 1352034
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a 5-HT1B receptor on CHO cells: functional responses in the absence of radioligand binding.
Giles H; Lansdell SJ; Bolofo ML; Wilson HL; Martin GR
Br J Pharmacol; 1996 Mar; 117(6):1119-26. PubMed ID: 8882605
[TBL] [Abstract][Full Text] [Related]
16. Uncoupling of the platelet alpha 2-adrenoceptor adenylate cyclase system by N-ethylmaleimide and the resulting effect on receptor density and sensitivity.
GarcĂa-Sevilla JA; Areso P; Giralt MT; Ulibarri I
Eur J Pharmacol; 1988 Jan; 145(1):91-5. PubMed ID: 2832185
[TBL] [Abstract][Full Text] [Related]
17. Human 5-HT7 receptor-induced inactivation of forskolin-stimulated adenylate cyclase by risperidone, 9-OH-risperidone and other "inactivating antagonists".
Toohey N; Klein MT; Knight J; Smith C; Teitler M
Mol Pharmacol; 2009 Sep; 76(3):552-9. PubMed ID: 19509219
[TBL] [Abstract][Full Text] [Related]
18. Pharmacology of 5-hydroxytryptamine-1A receptors which inhibit cAMP production in hippocampal and cortical neurons in primary culture.
Dumuis A; Sebben M; Bockaert J
Mol Pharmacol; 1988 Feb; 33(2):178-86. PubMed ID: 2828913
[TBL] [Abstract][Full Text] [Related]
19. A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system.
Dumuis A; Bouhelal R; Sebben M; Cory R; Bockaert J
Mol Pharmacol; 1988 Dec; 34(6):880-7. PubMed ID: 2849052
[TBL] [Abstract][Full Text] [Related]
20. Serotonin-1C sites in the choroid plexus are not linked in a stimulatory or inhibitory way to adenylate cyclase.
Palacios JM; Markstein R; Pazos A
Brain Res; 1986 Aug; 380(1):151-4. PubMed ID: 3019464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]